Valuation : Biogen Inc.

Market Cap 32.01B 27.56B 25.88B 23.62B 44.38B 3,046B 44.7B 307B 119B 1,544B 120B 118B 5,114B P/E 2026 *
38.5x
P/E 2027 * 19x
Enterprise Value 36.95B 31.81B 29.87B 27.27B 51.22B 3,516B 51.59B 354B 138B 1,783B 139B 136B 5,903B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.23x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day-0.85%
1 week-0.67%
Current month+6.75%
1 month+6.75%
3 months+12.70%
6 months+17.73%
Current year+23.10%
1 week 213.58
Extreme 213.58
222.85
1 month 199.58
Extreme 199.58
222.85
Current year 160.36
Extreme 160.3645
222.85
1 year 133.53
Extreme 133.53
222.85
3 years 110.04
Extreme 110.035
270.5
5 years 110.04
Extreme 110.035
341.29
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
1/5/26 Exercice

Executive/Senior Manager

2,333 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-0.67%+55.16%-18.97% 32.01B
+0.62%-3.55%+38.27%-3.32% 79.79B
+0.43%+1.89%-18.05%-37.01% 58.85B
+1.70%+1.04%+480.16%+24.12% 56.03B
+2.15%-2.13%-1.37%+30.77% 51.26B
+2.18%0.00%+10.44%+165.70% 47.68B
-0.92%-3.72%+43.31%+90.95% 24.98B
-2.12%+2.11%-3.61%+189.46% 23.05B
+1.65%+1.06%+61.41%+115.88% 16.31B
-3.91%-3.91%-8.84%+773.77% 15.64B
Average -0.25%-0.75%+65.69%+133.14% 40.56B
Weighted average by Cap. +0.14%-1.34%+81.24%+70.04%

Financials

2026 *2027 *
Net sales 10.44B 8.99B 8.44B 7.71B 14.48B 994B 14.58B 100B 38.92B 504B 39.21B 38.36B 1,668B 10.66B 9.18B 8.62B 7.87B 14.78B 1,014B 14.88B 102B 39.73B 514B 40.02B 39.15B 1,703B
Net income 953M 821M 771M 703M 1.32B 90.68B 1.33B 9.13B 3.55B 45.98B 3.58B 3.5B 152B 1.9B 1.64B 1.54B 1.4B 2.63B 181B 2.65B 18.19B 7.08B 91.64B 7.13B 6.98B 303B
Net Debt 4.94B 4.25B 3.99B 3.64B 6.84B 470B 6.89B 47.29B 18.4B 238B 18.54B 18.13B 789B 2.42B 2.08B 1.96B 1.79B 3.36B 230B 3.38B 23.18B 9.02B 117B 9.09B 8.89B 387B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
31/08/26 US$216.65 -0.85% 831,004
28/08/26 US$218.50 -1.35% 517,484
27/08/26 US$221.50 +0.19% 497,524
26/08/26 US$221.07 +0.14% 647,334
25/08/26 US$220.77 +1.21% 495,435
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
216.65USD
Average target price
236.22USD
Spread / Average Target
+9.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock